Date | 9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | 12/31/2021 | 6/30/2021 |
---|---|---|---|---|---|---|---|---|
Cash and Cash Equivalents | $11,634.00 | $52,152.00 | $94,300.00 | $391,924.00 | -- | -- | -- | -- |
Accounts Receivable Net Current | -- | -- | -- | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
Prepaid Expenses and Other Current Assets | -- | -- | -- | -- | -- | -- | -- | -- |
Total Current Assets | $11,634.00 | $52,152.00 | $94,300.00 | $391,924.00 | $529,566.00 | $622,351.00 | -- | -- |
Property Plant and Equipement | -- | -- | -- | -- | -- | -- | -- | -- |
Intangible Assets Net | -- | -- | -- | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- | -- | -- | -- |
Other Assets | -- | -- | -- | -- | -- | -- | -- | -- |
Total Assets | $49,709,417.00 | $48,702,373.00 | $62,319,437.00 | $104,553,953.00 | $103,762,752.00 | $103,377,355.00 | $289,765.00 | -- |
Accounts Payable | $822,122.00 | $749,875.00 | $927,217.00 | $200,028.00 | $177,342.00 | $7,500.00 | -- | -- |
Accrued Liabilities | $1,007,126.00 | $674,508.00 | $565,128.00 | $648,885.00 | $130,000.00 | $140,315.00 | $151,503.00 | -- |
Total Current Liabilities | $8,941,930.00 | $7,749,160.00 | $6,657,472.00 | $4,885,387.00 | $3,863,016.00 | $3,703,489.00 | -- | -- |
Long Term Debt | -- | -- | -- | -- | -- | -- | -- | -- |
Additional Paid-in Capital | -- | -- | -- | -- | -- | -- | -- | -- |
Accumulated Other Comprehensive Loss | -- | -- | -- | -- | -- | -- | -- | -- |
Accumulated Deficit | $-8,182,806.00 | $-7,083,682.00 | $-6,086,149.00 | $-4,293,466.00 | $-3,133,453.00 | $-2,932,734.00 | $-20,095.00 | -- |
Total Stockholders' Equity | $-8,182,803.00 | $-7,083,679.00 | $-6,086,146.00 | $-4,293,463.00 | $-3,133,450.00 | $-2,932,731.00 | $4,905.00 | $25,000.00 |
Controlling Interest in Subsidiaries | -- | -- | -- | -- | -- | -- | -- | -- |
Total Liabilities and Equity | $49,709,417.00 | $48,702,373.00 | $62,319,437.00 | $104,553,953.00 | $103,762,752.00 | $103,377,355.00 | $289,765.00 | -- |
Date | 9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | 12/31/2021 | 6/30/2021 |
---|---|---|---|---|---|---|---|---|
Total Revenues | -- | -- | -- | -- | -- | -- | -- | -- |
Cost of Revenues | -- | -- | -- | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- | -- | -- | -- |
Research and Development | -- | -- | -- | -- | -- | -- | -- | -- |
Selling, General, and Administrative | -- | -- | -- | -- | -- | -- | -- | -- |
Total Operating Expenses | -- | -- | -- | -- | -- | -- | $20,095.00 | -- |
Loss from Operations | $-2,118,291.00 | $-225,182.00 | $-1,230,502.00 | $-1,703,385.00 | $-829,034.00 | $-117,309.00 | -- | -- |
Loss Before Income Taxes | $-62,543.00 | $475,170.00 | $-509,717.00 | $-147,953.00 | -- | -- | -- | -- |
Earnings Per Share Basic | $-0.02 | $-0.03 | $-0.05 | $-0.03 | $0.02 | $-0.03 | -- | -- |
Weighted Average Shares Basic | 8,789,806 | 8,597,345 | 13,485,199 | 13,000,236 | 13,000,236 | 13,485,199 | -- | 2,500,000 |
Earnings Per Share Diluted | $-0.06 | $-0.03 | -- | -- | -- | -- | -- | -- |
Weighted Average Shares Diluted | 8,680,609 | 8,992,588 | -- | -- | -- | -- | -- | -- |
Common Stock Shares Authorized | 100,000,000 | 100,000,000 | 100,000,000 | 100,000,000 | 100,000,000 | 100,000,000 | 100,000,000 | -- |
Common Stock Shares Outstanding | 2,990,897 | 2,990,897 | 2,990,897 | 2,990,897 | 2,990,897 | 2,990,897 | 2,875,000 | -- |
Common Stock Value | $3.00 | $3.00 | $3.00 | $3.00 | $3.00 | $3.00 | $3.00 | -- |
Common Stock Par Or Stated Value Per Share | -- | -- | -- | -- | -- | -- | -- | -- |
Payments Of Dividends Common Stock | -- | -- | -- | -- | -- | -- | -- | -- |
Preferred Stock Shares Authorized | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | -- |
Preferred Stock Shares Outstanding | -- | -- | -- | -- | -- | -- | -- | -- |
Preferred Stock Value | -- | -- | -- | -- | -- | -- | -- | -- |
Preferred Stock Par Or Stated Value Per Share | -- | -- | -- | -- | -- | -- | -- | -- |
Share Price | -- | -- | -- | -- | -- | -- | -- | -- |